5-[(3S)-3-[[(2S)-2-(methylamino)propanoyl]amino]-5-[(2-methylnaphthalen-1-yl)methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-1-yl]-5-oxopentanoic acid;hydrochloride

C30H35ClN4O5 — CID 118076634

IUPAC5-[(3S)-3-[[(2S)-2-(methylamino)propanoyl]amino]-5-[(2-methylnaphthalen-1-yl)methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-1-yl]-5-oxopentanoic acid;hydrochloride
SMILESCN[C@@H](C)C(=O)N[C@H]1CN(C(=O)CCCC(=O)O)c2ccccc2N(Cc2c(C)ccc3ccccc23)C1=O.Cl
InChIInChI=1S/C30H34N4O5.ClH/c1-19-15-16-21-9-4-5-10-22(21)23(19)17-34-26-12-7-6-11-25(26)33(27(35)13-8-14-28(36)37)18-24(30(34)39)32-29(38)20(2)31-3;/h4-7,9-12,15-16,20,24,31H,8,13-14,17-18H2,1-3H3,(H,32,38)(H,36,37);1H/t20-,24-;/m0./s1
InChIKeyFPNVMXAZASMMIS-OGZMHEHASA-N
MW567.09 g/mol
LogP3.80
Rot. Bonds9

About 5-[(3S)-3-[[(2S)-2-(methylamino)propanoyl]amino]-5-[(2-methylnaphthalen-1-yl)methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-1-yl]-5-oxopentanoic acid;hydrochloride

5-[(3S)-3-[[(2S)-2-(methylamino)propanoyl]amino]-5-[(2-methylnaphthalen-1-yl)methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-1-yl]-5-oxopentanoic acid;hydrochloride (PubChem CID 118076634) has the molecular formula C30H35ClN4O5 and a molecular weight of 567.09 g/mol. Its IUPAC name is 5-[(3S)-3-[[(2S)-2-(methylamino)propanoyl]amino]-5-[(2-methylnaphthalen-1-yl)methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-1-yl]-5-oxopentanoic acid;hydrochloride.

Molecular Properties

Compound Name5-[(3S)-3-[[(2S)-2-(methylamino)propanoyl]amino]-5-[(2-methylnaphthalen-1-yl)methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-1-yl]-5-oxopentanoic acid;hydrochloride
PubChem CID118076634
Molecular FormulaC30H35ClN4O5
Molecular Weight567.09 g/mol
Exact Mass566.23
IUPAC Name5-[(3S)-3-[[(2S)-2-(methylamino)propanoyl]amino]-5-[(2-methylnaphthalen-1-yl)methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-1-yl]-5-oxopentanoic acid;hydrochloride
SMILESCN[C@@H](C)C(=O)N[C@H]1CN(C(=O)CCCC(=O)O)c2ccccc2N(Cc2c(C)ccc3ccccc23)C1=O.Cl
InChIInChI=1S/C30H34N4O5.ClH/c1-19-15-16-21-9-4-5-10-22(21)23(19)17-34-26-12-7-6-11-25(26)33(27(35)13-8-14-28(36)37)18-24(30(34)39)32-29(38)20(2)31-3;/h4-7,9-12,15-16,20,24,31H,8,13-14,17-18H2,1-3H3,(H,32,38)(H,36,37);1H/t20-,24-;/m0./s1
InChIKeyFPNVMXAZASMMIS-OGZMHEHASA-N
XLogP3.80
TPSA119.05 Ų
H-Bond Donors3
H-Bond Acceptors5
Rotatable Bonds9
Heavy Atoms40
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500567.09
LogP ≤ 53.80
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 105

Analyze 5-[(3S)-3-[[(2S)-2-(methylamino)propanoyl]amino]-5-[(2-methylnaphthalen-1-yl)methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-1-yl]-5-oxopentanoic acid;hydrochloride with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-[(3S)-3-[[(2S)-2-(methylamino)propanoyl]amino]-5-[(2-methylnaphthalen-1-yl)methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-1-yl]-5-oxopentanoic acid;hydrochloride?
The IUPAC name of 5-[(3S)-3-[[(2S)-2-(methylamino)propanoyl]amino]-5-[(2-methylnaphthalen-1-yl)methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-1-yl]-5-oxopentanoic acid;hydrochloride (CID 118076634) is 5-[(3S)-3-[[(2S)-2-(methylamino)propanoyl]amino]-5-[(2-methylnaphthalen-1-yl)methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-1-yl]-5-oxopentanoic acid;hydrochloride.
What is the SMILES notation for 5-[(3S)-3-[[(2S)-2-(methylamino)propanoyl]amino]-5-[(2-methylnaphthalen-1-yl)methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-1-yl]-5-oxopentanoic acid;hydrochloride?
The canonical SMILES for 5-[(3S)-3-[[(2S)-2-(methylamino)propanoyl]amino]-5-[(2-methylnaphthalen-1-yl)methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-1-yl]-5-oxopentanoic acid;hydrochloride is CN[C@@H](C)C(=O)N[C@H]1CN(C(=O)CCCC(=O)O)c2ccccc2N(Cc2c(C)ccc3ccccc23)C1=O.Cl.
What is the InChIKey of 5-[(3S)-3-[[(2S)-2-(methylamino)propanoyl]amino]-5-[(2-methylnaphthalen-1-yl)methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-1-yl]-5-oxopentanoic acid;hydrochloride?
The InChIKey is FPNVMXAZASMMIS-OGZMHEHASA-N. The full InChI is InChI=1S/C30H34N4O5.ClH/c1-19-15-16-21-9-4-5-10-22(21)23(19)17-34-26-12-7-6-11-25(26)33(27(35)13-8-14-28(36)37)18-24(30(34)39)32-29(38)20(2)31-3;/h4-7,9-12,15-16,20,24,31H,8,13-14,17-18H2,1-3H3,(H,32,38)(H,36,37);1H/t20-,24-;/m0./s1.
What are the key properties of 5-[(3S)-3-[[(2S)-2-(methylamino)propanoyl]amino]-5-[(2-methylnaphthalen-1-yl)methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-1-yl]-5-oxopentanoic acid;hydrochloride?
5-[(3S)-3-[[(2S)-2-(methylamino)propanoyl]amino]-5-[(2-methylnaphthalen-1-yl)methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-1-yl]-5-oxopentanoic acid;hydrochloride has a molecular weight of 567.09 g/mol, XLogP of 3.80, 9 rotatable bonds, 3 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[(3S)-3-[[(2S)-2-(methylamino)propanoyl]amino]-5-[(2-methylnaphthalen-1-yl)methyl]-4-oxo-2,3-dihydro-1,5-benzodiazepin-1-yl]-5-oxopentanoic acid;hydrochloride is sourced from PubChem (CID 118076634), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).